These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26328923)

  • 1. Class effect of beta-blockers in survivors of ST-elevation myocardial infarction: A nationwide cohort study using an insurance claims database.
    Lin TT; Arnold Chan K; Chen HM; Lai CL; Lai MS
    Sci Rep; 2015 Sep; 5():13692. PubMed ID: 26328923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of immediate beta-blocker therapy on mortality in patients with ST-segment elevation myocardial infarction.
    Hirschl MM; Wollmann CG; Erhart F; Brunner W; Pfeffel F; Gattermeier M; Steger F; Mayr H
    Crit Care Med; 2013 Jun; 41(6):1396-404. PubMed ID: 23528803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
    Soumerai SB; McLaughlin TJ; Spiegelman D; Hertzmark E; Thibault G; Goldman L
    JAMA; 1997 Jan; 277(2):115-21. PubMed ID: 8990335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Carvedilol versus β1-selective β blockers (bisoprolol, metoprolol, and nebivolol) in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Seo GW; Kim DK; Kim KH; Seol SH; Jin HY; Yang TH; Ahn Y; Jeong MH; Song PS; Kim DI;
    Am J Cardiol; 2015 Nov; 116(10):1502-8. PubMed ID: 26520013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the clinical outcome of different beta-blockers in heart failure patients: a retrospective nationwide cohort study.
    Bølling R; Scheller NM; Køber L; Poulsen HE; Gislason GH; Torp-Pedersen C
    Eur J Heart Fail; 2014 Jun; 16(6):678-84. PubMed ID: 24706485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.
    Bangalore S; Bhatt DL; Steg PG; Weber MA; Boden WE; Hamm CW; Montalescot G; Hsu A; Fox KA; Lincoff AM
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):872-81. PubMed ID: 25271049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
    Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
    Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
    Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
    JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selection of β-blocker after successful reperfusion in patients with ST-elevation myocardial infarction.
    Jang HJ; Suh J; Kwon SW; Park SD; Oh PC; Moon J; Lee K; Kang WC; Jung IH; An H; Kim TH
    Perfusion; 2020 May; 35(4):338-347. PubMed ID: 31608761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.
    Andersen SS; Hansen ML; Gislason GH; Folke F; Schramm TK; Fosbøl E; Sørensen R; Rasmussen S; Abildstrøm SZ; Madsen M; Køber L; Torp-Pedersen C
    Cardiology; 2009; 112(2):144-50. PubMed ID: 18612201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of different beta-blockers on left-ventricular volume and function after primary coronary stenting in acute myocardial infarction.
    Lee SH; Yoon SB; Cho JR; Choi S; Jung JH; Lee N
    Angiology; 2008 Dec-2009 Jan; 59(6):676-81. PubMed ID: 18388053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study.
    Sorbets E; Steg PG; Young R; Danchin N; Greenlaw N; Ford I; Tendera M; Ferrari R; Merkely B; Parkhomenko A; Reid C; Tardif JC; Fox KM;
    Eur Heart J; 2019 May; 40(18):1399-1407. PubMed ID: 30590529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological intervention in hypertension using beta-blockers: Real-world evidence for long-term effectiveness.
    Sabidó M; Hohenberger T; Grassi G
    Pharmacol Res; 2018 Apr; 130():191-197. PubMed ID: 29366925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of β-Blocker in Patients With Cirrhosis and Acute Myocardial Infarction: A 13-Year Nationwide Population-Based Study in Asia.
    Wu VC; Chen SW; Ting PC; Chang CH; Wu M; Lin MS; Hsieh MJ; Wang CY; Chang SH; Hung KC; Hsieh IC; Chu PH; Wu CS; Lin YS
    J Am Heart Assoc; 2018 Oct; 7(19):e008982. PubMed ID: 30371327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction.
    Bao B; Ozasa N; Morimoto T; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Shiomi H; Tada T; Tazaki J; Kato Y; Hayano M; Natsuaki M; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T
    Cardiovasc Interv Ther; 2013 Apr; 28(2):139-47. PubMed ID: 23054967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioselective Versus Nonselective β-Blockers After Myocardial Infarction in Adults With Chronic Obstructive Pulmonary Disease.
    Chung CM; Lin MS; Chang ST; Wang PC; Yang TY; Lin YS
    Mayo Clin Proc; 2022 Mar; 97(3):531-546. PubMed ID: 35135688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.
    Ozasa N; Kimura T; Morimoto T; Hou H; Tamura T; Shizuta S; Nakagawa Y; Furukawa Y; Hayashi Y; Nakao K; Matsuzaki M; Nobuyoshi M; Mitsudo K;
    Am J Cardiol; 2010 Nov; 106(9):1225-33. PubMed ID: 21029817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.